Detectiome
AI-powered blood test for early detection of multiple cancers, tuned for Middle Eastern genetics
AIHealthTechPaid Unclaimed listing
Detectiome develops Revonco, a blood test that combines multiomics data with AI to detect multiple cancer types before symptoms appear, with models built for Middle Eastern populations. Founded in 2022 and based at the In5 Tech incubator in Dubai Science Park, the company currently offers Revonco to hospitals and researchers for pilot studies and clinical trials rather than as a direct-to-consumer test. It was named Healthtech Startup of the Year by Entrepreneur Middle East in 2022 and won the Mohammed Bin Rashid Innovation Fund's Most Impactful Startup award.